Massivemarkets

SEC Form 4

Acrivon Therapeutics, Inc. (ACRV) insider trading

In the 12 months to Nov 20, 2026, 7 ACRV insiders reported open-market sales of $39.8K across 9 filings; 3 insiders bought $114.3K.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$39.8K
9 filings · 7 insiders
Open-market purchases
$114.3K
3 filings

Who traded ACRV, and when

  • Purchase
  • Sale

ACRV daily close from Nov 20, 2025 to Nov 20, 2026, between $1.15 and $3.01, last $1.15. 9 sale and 3 purchase filings by 7 insiders, marked at their filing dates. Kristina Masson, EVP - Business Operations: sold $33.4K and bought $82.1K across 3 filings, first filed Jan 16, 2026, last Aug 27, 2026. Eric Devroe, Chief Operating Officer: sold $1.2K and bought $17.2K across 2 filings, first filed Jan 15, 2026, last Aug 20, 2026. Adam D. Levy, Chief Financial Officer: sold $1.8K and bought $15.0K across 2 filings, first filed Jan 16, 2026, last Aug 6, 2026. Mary Miller, Chief Legal Officer: sold $1.4K across 2 filings, first filed Jul 23, 2026, last Aug 20, 2026. Peter Blume-Jensen, President and CEO: sold $973 across 1 filing, first filed Aug 20, 2026, last Aug 20, 2026. Erick Gamelin, Chief Development Officer: sold $804 across 1 filing, first filed Aug 20, 2026, last Aug 20, 2026. Katharine Peterson, Chief Accounting Officer: sold $203 across 1 filing, first filed Aug 20, 2026, last Aug 20, 2026.

Largest mark · tap a row for others

Kristina Masson · EVP - Business Operations

Purchase $82,124

49,000 shares at $1.68 avg

Filed Jan 16, 2026 · traded Jan 14

Close on filing date $1.98

ACRV daily closelast $1.15

Kristina Masson · EVP - Business Operations

$33.4K sold$82.1K bought

Eric Devroe · Chief Operating Officer

$1.2K sold$17.2K bought

Adam D. Levy · Chief Financial Officer

$1.8K sold$15.0K bought

Mary Miller · Chief Legal Officer

$1.4K sold

Peter Blume-Jensen · President and CEO

$973 sold

Erick Gamelin · Chief Development Officer

$804 sold

Katharine Peterson · Chief Accounting Officer

$203 sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

12 filings in the last 12 months
Other insider activity (not market trades) · 42 records
  • Tax withholding17 records
  • Tax withholding (sold to cover)8 records
  • Grants and awards17 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Counted once
When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

Frequently asked questions

Has Acrivon Therapeutics, Inc.'s CEO sold stock?

Yes. Peter Blume-Jensen (CEO) sold 484 shares ($973) in Aug 2026.

How current is ACRV’s insider data?

These are ACRV Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track ACRV insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for ACRV every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.